Loading...

Joshua Woolley, MD, PhD

Title(s)Associate Professor, Psychiatry
SchoolSchool of Medicine
Address4150 Clement St
San Francisco CA 94121
Phone415-221-4810 ext. 4117
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency 2011School of Medicine
    University of California, San FranciscoM.D.2007 School of Medicine
    University of California, San FranciscoPh.D.2005 Graduate Division (Neuroscience)
    Brown University, Providence, RIBachelor of Science1999Biology and Philosophy

    Collapse Overview 
    Collapse Overview
    Dr. Josh Woolley is an Associate Professor in Residence in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco (UCSF) as well as a staff psychiatrist in Mental Health at the San Francisco Veterans Affairs Medical Center (SFVAMC). He is Board Certified in Psychiatry by the American Board of Psychiatry and Neurology. He is the Director of the Bonding and Attunement in Neuropsychiatric Disorders (BAND) lab at UCSF that focuses on understanding and treating social deficits in neuropsychiatric disorders including schizophrenia, substance use disorders, and mood disorders. He is also the Director of the Translational Psychedelic Research (TrPR) Program at UCSF, which brings together scientists and care providers across disciplines to understand how psilocybin, LSD, ketamine, MDMA, and related compounds impact the brain and other organ systems.

    In addition to his work as a researcher, Dr. Woolley is also a dedicated mentor, clinician, and educator who enjoys training the next generation of clinicians and scientists. Over the course of his career, Dr. Woolley has mentored over 80 research assistants, over 20 postdoctoral fellows and several junior faculty members. He is the Associate Director of the Psychosis Clinic at the SFVA where he supervises and trains medical students, psychiatry residents, and clinical and research fellows. He has also served as the Co-Director of the first-year medical school psychiatry course Brain Mind and Behavior, and has been given several awards for his dedication to teaching.

    Dr. Woolley has received numerous intramural and extramural awards including the NARSAD Young Investigator Award from the Brain & Behavior Research Foundation, the Young Investigator Award, as well as travel awards from the California Society for Addiction Medicine, the American Society of Clinical Psychopharmacology, and the American Academy of Addiction Psychiatry. He is an Associate Member of the American College of Neuropsychopharmacology. His work is supported by the Department of Veteran Affairs as well as the Department of Defense, philanthropy, and industry. He has also published his work widely in high-impact journals including Schizophrenia Bulletin, Biological Psychiatry, and American Journal of Psychiatry, among others.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Student Projects
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia. Horm Behav. 2020 Dec 28; 128:104915. Bradley ER, Tai M, Hankin M, Woolley JD. PMID: 33340522.
      View in: PubMed   Mentions: 1     Fields:    
    2. Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience. ACS Pharmacol Transl Sci. 2021 Apr 09; 4(2):526-532. PMID: 33860182.
      View in: PubMed   Mentions:
    3. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine. 2020 Oct; 27:100538. Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. PMID: 33150319.
      View in: PubMed   Mentions:
    4. Automatic Imitation in Comorbid PTSD & Alcohol Use Disorder and Controls: an RCT of Intranasal Oxytocin. Psychoneuroendocrinology. 2020 10; 120:104787. Morrison TE, De Coster L, Stauffer CS, Wen J, Ahmadi E, Delucchi K, O'Donovan A, Woolley J. PMID: 32745891.
      View in: PubMed   Mentions:    Fields:    
    5. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemp Clin Trials. 2020 Aug; 95:106074. Flanagan JC, Mitchell JM, Baker NL, Woolley J, Wangelin B, Back SE, McQuaid JR, Neylan TC, Wolfe WR, Brady KT. PMID: 32561468.
      View in: PubMed   Mentions:    Fields:    
    6. Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial. J Subst Abuse Treat. 2020 09; 116:108059. Stauffer CS, Moschetto JM, McKernan S, Meinzer N, Chiang C, Rapier R, Hsiang E, Norona J, Borsari B, Woolley JD. PMID: 32741502.
      View in: PubMed   Mentions:    Fields:    
    7. Social integration and inflammation in individuals with and without posttraumatic stress disorder. Brain Behav Immun. 2020 10; 89:168-174. Ahmadian AJ, Lin JE, Neylan TC, Woolley JD, O'Donovan A, Cohen BE. PMID: 32534985.
      View in: PubMed   Mentions:    Fields:    
    8. Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial. Schizophr Bull. 2020 04 10; 46(3):661-669. Abram SV, De Coster L, Roach BJ, Mueller BA, van Erp TGM, Calhoun VD, Preda A, Lim KO, Turner JA, Ford JM, Mathalon DH, Woolley JD. PMID: 31595302.
      View in: PubMed   Mentions:    Fields:    
    9. Six month durability of targeted cognitive training supplemented with social cognition exercises in schizophrenia. Schizophr Res Cogn. 2020 Jun; 20:100171. Miley K, Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B, Woolley J, Hooker CI, Biagianti B, Ramsay I, Vinogradov S. PMID: 31908976.
      View in: PubMed   Mentions:
    10. Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial. Alcohol Clin Exp Res. 2019 12; 43(12):2627-2636. Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD. PMID: 31610033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Oxytocin increases eye gaze in schizophrenia. Schizophr Res. 2019 10; 212:177-185. Bradley ER, Seitz A, Niles AN, Rankin KP, Mathalon DH, O'Donovan A, Woolley JD. PMID: 31416746.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial. Neuropsychopharmacology. 2019 10; 44(11):1925-1931. De Coster L, Lin L, Mathalon DH, Woolley JD. PMID: 31103018.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Psychedelic-Assisted Group Therapy: A Systematic Review. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):174-188. Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. PMID: 30950777.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Victory is its own reward: oxytocin increases costly competitive behavior in schizophrenia. Psychol Med. 2020 03; 50(4):674-682. Bradley ER, Brustkern J, De Coster L, van den Bos W, McClure SM, Seitz A, Woolley JD. PMID: 30944045.
      View in: PubMed   Mentions: 1     Fields:    
    15. Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity. Biol Psychiatry. 2019 06 15; 85(12):e75-e76. Marton T, Barnes DE, Wallace A, Woolley JD. PMID: 30926131.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial. Trials. 2019 Feb 21; 20(1):145. Stauffer CS, Moschetto JM, McKernan SM, Hsiang E, Borsari B, Woolley JD. PMID: 30791944.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    17. Oxytocin does not improve working memory in schizophrenia. Schizophr Res. 2019 06; 208:486-487. Bradley ER, van Nieuwenhuizen A, Abram S, Niles AN, Woolley JD. PMID: 30712813.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Social motivation in schizophrenia: The impact of oxytocin on vigor in the context of social and nonsocial reinforcement. J Abnorm Psychol. 2018 01; 127(1):116-128. Fulford D, Treadway M, Woolley J. PMID: 29369669.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Effects of oxytocin administration on receiving help. Emotion. 2018 Oct; 18(7):980-988. Human LJ, Woolley JD, Mendes WB. PMID: 29172621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis. Schizophr Bull. 2017 10 21; 43(6):1291-1303. Bürkner PC, Williams DR, Simmons TC, Woolley JD. PMID: 28586471.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Feasibility and preliminary efficacy of remotely delivering cognitive training to people with schizophrenia using tablets. Schizophr Res Cogn. 2017 Dec; 10:7-14. Biagianti B, Fisher M, Howard L, Rowlands A, Vinogradov S, Woolley J. PMID: 28824850.
      View in: PubMed   Mentions:
    22. Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. Neurosci Biobehav Rev. 2017 Sep; 80:36-56. Bradley ER, Woolley JD. PMID: 28506922.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Combining oxytocin administration and positive emotion inductions: Examining social perception and analytical performance. Horm Behav. 2017 04; 90:120-128. Human LJ, Thorson KR, Woolley JD, Mendes WB. PMID: 28324706.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report. Psychiatr Rehabil J. 2017 03; 40(1):21-32. Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B, Kermott A, Woolley J, Vinogradov S. PMID: 28368179.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    25. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls. Psychol Med. 2017 May; 47(7):1311-1322. Woolley JD, Chuang B, Fussell C, Scherer S, Biagianti B, Fulford D, Mathalon DH, Vinogradov S. PMID: 28091349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Chronic Psychotic Disorders. JMIR Ment Health. 2016 Dec 13; 3(4):e52. Biagianti B, Schlosser D, Nahum M, Woolley J, Vinogradov S. PMID: 27965190.
      View in: PubMed   Mentions:
    27. American Alcohol Photo Stimuli (AAPS): A standardized set of alcohol and matched non-alcohol images. Am J Drug Alcohol Abuse. 2017 11; 43(6):647-655. Stauffer CS, Dobberteen L, Woolley JD. PMID: 27893279.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addict Res Theory. 2016; 24(6):490-498. Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD. PMID: 28503120.
      View in: PubMed   Mentions:
    29. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. Psychopharmacology (Berl). 2016 07; 233(13):2571-80. Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S. PMID: 27137199.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder. J Addict Med. 2016 May-Jun; 10(3):182-9. Mitchell JM, Arcuni PA, Weinstein D, Woolley JD. PMID: 27159342.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    31. Intranasal Oxytocin Mechanisms Can Be Better Understood, but Its Effects on Social Cognition and Behavior Are Not to Be Sniffed At. Biol Psychiatry. 2016 Apr 15; 79(8):e49-50. Quintana DS, Woolley JD. PMID: 26212900.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. Impaired Recognition and Regulation of Disgust Is Associated with Distinct but Partially Overlapping Patterns of Decreased Gray Matter Volume in the Ventroanterior Insula. Biol Psychiatry. 2015 Oct 01; 78(7):505-14. Woolley JD, Strobl EV, Sturm VE, Shany-Ur T, Poorzand P, Grossman S, Nguyen L, Eckart JA, Levenson RW, Seeley WW, Miller BL, Rankin KP. PMID: 25890642.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia. Psychoneuroendocrinology. 2015 Mar; 53:217-22. Woolley JD, Lam O, Chuang B, Ford JM, Mathalon DH, Vinogradov S. PMID: 25637811.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    34. Can we bottle psychosocial treatments for addiction? The role of oxytocin. J Clin Psychiatry. 2014 Sep; 75(9):1028-9. Stauffer CS, Woolley JD. PMID: 25295428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    35. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology. 2014 Sep; 47:116-25. Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S. PMID: 25001961.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    36. Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. Psychol Med. 2014 Dec; 44(16):3491-501. Modinos G, Allen P, Frascarelli M, Tognin S, Valmaggia L, Xenaki L, Keedwell P, Broome M, Valli I, Woolley J, Stone JM, Mechelli A, Phillips ML, McGuire P, Fusar-Poli P. PMID: 25066827.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    37. Satiety-related hormonal dysregulation in behavioral variant frontotemporal dementia. Neurology. 2014 Feb 11; 82(6):512-20. Woolley JD, Khan BK, Natesan A, Karydas A, Dallman M, Havel P, Miller BL, Rankin KP. PMID: 24415571.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade. Appetite. 2014 Mar; 74:92-100. Daubenmier J, Lustig RH, Hecht FM, Kristeller J, Woolley J, Adam T, Dallman M, Epel E. PMID: 24291355.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med. 2014 Feb; 44(3):499-506. Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH, . PMID: 23701858.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med. 2014 Feb; 44(3):489-98. Tognin S, Riecher-Rössler A, Meisenzahl EM, Wood SJ, Hutton C, Borgwardt SJ, Koutsouleris N, Yung AR, Allen P, Phillips LJ, McGorry PD, Valli I, Velakoulis D, Nelson B, Woolley J, Pantelis C, McGuire P, Mechelli A. PMID: 23659473.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    41. BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. Curr Alzheimer Res. 2012 Sep; 9(7):815-21. Woolley JD, Strobl EV, Shelly WB, Karydas AM, Robin Ketelle RN, Wolkowitz OM, Miller BL, Rankin KP. PMID: 21605064.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman. Psychosomatics. 2012 May-Jun; 53(3):280-4. Khan BK, Woolley JD, Chao S, See T, Karydas AM, Miller BL, Rankin KP. PMID: 22284422.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    43. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 Feb; 72(2):126-33. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. PMID: 21382304.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    44. Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report. Gen Hosp Psychiatry. 2010 Nov-Dec; 32(6):648.e5-8. Woolley J, Douglas VC, Cree BA. PMID: 21112466.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Frontotemporal dementia and mania. Am J Psychiatry. 2007 Dec; 164(12):1811-6. Woolley JD, Wilson MR, Hung E, Gorno-Tempini ML, Miller BL, Shim J. PMID: 18056235.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007 Oct 02; 69(14):1424-33. Woolley JD, Gorno-Tempini ML, Seeley WW, Rankin K, Lee SS, Matthews BR, Miller BL. PMID: 17909155.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    47. Opposing effects of intra-nucleus accumbens mu and kappa opioid agonists on sensory specific satiety. Neuroscience. 2007 Jun 08; 146(4):1445-52. Woolley JD, Lee BS, Kim B, Fields HL. PMID: 17445988.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    48. Nucleus accumbens opioid signaling conditions short-term flavor preferences. Neuroscience. 2007 Apr 25; 146(1):19-30. Woolley JD, Lee BS, Taha SA, Fields HL. PMID: 17320293.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    49. Nucleus accumbens opioids regulate flavor-based preferences in food consumption. Neuroscience. 2006 Nov 17; 143(1):309-17. Woolley JD, Lee BS, Fields HL. PMID: 17049180.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    50. Endogenous opioids encode relative taste preference. Eur J Neurosci. 2006 Aug; 24(4):1220-6. Taha SA, Norsted E, Lee LS, Lang PD, Lee BS, Woolley JD, Fields HL. PMID: 16925586.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    51. The autonomic and behavioral profile of emotional dysregulation. Neurology. 2004 Nov 09; 63(9):1740-3. Woolley JD, Gorno-Tempini ML, Werner K, Rankin KP, Ekman P, Levenson RW, Miller BL. PMID: 15534273.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Cognitive and behavioral profile in a case of right anterior temporal lobe neurodegeneration. Cortex. 2004 Sep-Dec; 40(4-5):631-44. Gorno-Tempini ML, Rankin KP, Woolley JD, Rosen HJ, Phengrasamy L, Miller BL. PMID: 15505973.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    53. Buccofacial apraxia and the expression of emotion. Ann N Y Acad Sci. 2003 Dec; 1000:395-401. Woolley JD. PMID: 14766655.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Joshua's Networks
    Concepts (227)
    Derived automatically from this person's publications.
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _